AL-1811

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAL-1811
Drug Alias Nameruthenium-based complex (Almetis)AL-1811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR modulators
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlmetis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlmetis
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A